LENZ (LENZ)
Commercializes VIZZ, an FDA-approved aceclidine eye drop for adult presbyopia.
$4.18
After hours+0.05 (+1.26%)
At close$4.13(+1.10%)
Something off on this page? Send us feedback.
Next report
Nov 4, 26
in 43 days
EPS estimate
−$1.02
Revenue estimate
$4.5M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Jul '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.46−$0.53−$0.53−$0.59−$1.16−$1.32−$1.02Pending
Estimate−$0.42−$0.55−$0.58−$0.67−$0.91−$1.10−$1.05−$1.02
Surprise−9.5%+3.6%+8.6%+11.9%−27.5%−20.0%+2.9%—
RevenueReportedEstimate
Mar '25May '25Jul '25Nov '25Mar '26May '26Aug '26Nov '26
Reported——$5.0M$12.5M$1.6M$1.9M$5.5MPending
Estimate—$714.3K$714.3K$3.1M$3.1M$1.8M$2.4M$4.5M
Surprise——+600.0%+304.8%−48.5%+8.1%+130.8%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.35 | — | — |
| Sep 2028 | −$0.67 | — | — |
| Jun 2028 | −$0.83 | — | — |
| Mar 2028 | −$1.19 | — | — |
| Dec 2027 | −$0.69 | — | — |
| Sep 2027 | −$0.78 | — | — |
| Jun 2027 | −$0.86 | — | — |
| Mar 2027 | −$1.05 | — | — |
| Dec 2026 | −$0.84 | — | — |
| Nov 2026 | −$1.02 | — | — |
| Aug 2026 | −$1.05 | −$1.02 | +2.9% |
| May 2026 | −$1.10 | −$1.32 | −20.0% |
| Mar 2026 | −$0.91 | −$1.16 | −27.5% |
| Nov 2025 | −$0.67 | −$0.59 | +11.9% |
| Jul 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| Jun 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Dec 2022 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Dec 2021 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.35 | — | — | $33.0M | — | — | — |
| Sep 2028 | −$0.67 | — | — | $23.7M | — | — | — |
| Jun 2028 | −$0.83 | — | — | $19.8M | — | — | — |
| Mar 2028 | −$1.19 | — | — | $16.2M | — | — | — |
| Dec 2027 | −$0.69 | — | — | $10.3M | — | — | — |
| Sep 2027 | −$0.78 | — | — | $8.4M | — | — | — |
| Jun 2027 | −$0.86 | — | — | $7.2M | — | — | — |
| Mar 2027 | −$1.05 | — | — | $5.7M | — | — | — |
| Dec 2026 | −$0.84 | — | — | $5.2M | — | — | — |
| Nov 4, 2026 | −$1.02 | — | — | $4.5M | — | — | — |
| Aug 11, 2026 | −$1.05 | −$1.02 | +2.9% | $2.4M | $5.5M | +130.8% | −3.3% |
| May 11, 2026 | −$1.10 | −$1.32 | −20.0% | $1.8M | $1.9M | +8.1% | −20.8% |
| Mar 24, 2026 | −$0.91 | −$1.16 | −27.5% | $3.1M | $1.6M | −48.5% | −17.9% |
| Nov 5, 2025 | −$0.67 | −$0.59 | +11.9% | $3.1M | $12.5M | +304.8% | −23.5% |
| Jul 30, 2025 | |||||||
| May 7, 2025 | |||||||
| Mar 19, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 8, 2024 | |||||||
| Feb 27, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 14, 2023 | |||||||
| Jun 29, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 20, 2023 | |||||||
| Dec 30, 2022 | |||||||
| Nov 9, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 12, 2022 | |||||||
| Dec 30, 2021 | |||||||
| Sep 29, 2021 | |||||||
| Jun 29, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 |